Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our recommendation for VRTX stock.
The "Magnificent Seven" stocks currently trade at their cheapest valuation premium versus the remaining 493 companies in the S&P 500 (SNPINDEX: ^GSPC) since 2017, according to Goldman Sachs. But none ...
Cathie Wood has recently predicted that Tesla will reach $2600/share in five years' time. See why I reiterate my strong sell ...
The company is part of the BSE SmallCap index and has a market capitalisation of Rs 8,784 crore. It is involved in the ...
What this means is that anyone who put £10,000 into the stock at its peak would now have about £4,790 (I’m ignoring trading ...